Sepsis is a lethal disease in Australia and globally. There has never been a greater need to develop a test that can provide a rapid diagnosis.
James’ work focuses on the development and optimisation of new G6PD deficiency diagnostics to inform safe treatment of Plasmodium vivax malaria.
In his honours year he developed and validated a combined G6PD and haemoglobin test, that is high throughput and appropriate, for resource poor malaria endemic areas.
This work aims to expand access to primaquine treatment and to assist in attenuating the global burden of malaria.